113 related articles for article (PubMed ID: 38421702)
1. A Machine Learning Method for a Blood Diagnostic Model of Pancreatic Cancer Based on microRNA Signatures.
Huang B; Xin C; Yan H; Yu Z
Crit Rev Immunol; 2024; 44(3):13-23. PubMed ID: 38421702
[TBL] [Abstract][Full Text] [Related]
2. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
Sohrabi E; Rezaie E; Heiat M; Sefidi-Heris Y
Biochem Genet; 2021 Oct; 59(5):1326-1358. PubMed ID: 33813720
[TBL] [Abstract][Full Text] [Related]
3. A machine learning approach identified a diagnostic model for pancreatic cancer through using circulating microRNA signatures.
Alizadeh Savareh B; Asadzadeh Aghdaie H; Behmanesh A; Bashiri A; Sadeghi A; Zali M; Shams R
Pancreatology; 2020 Sep; 20(6):1195-1204. PubMed ID: 32800647
[TBL] [Abstract][Full Text] [Related]
4. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
5. A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer.
Deng B; Wang M; Liu Z
Medicine (Baltimore); 2020 Sep; 99(38):e22261. PubMed ID: 32957376
[TBL] [Abstract][Full Text] [Related]
6. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
7. Proposing new early detection indicators for pancreatic cancer: Combining machine learning and neural networks for serum miRNA-based diagnostic model.
Chi H; Chen H; Wang R; Zhang J; Jiang L; Zhang S; Jiang C; Huang J; Quan X; Liu Y; Zhang Q; Yang G
Front Oncol; 2023; 13():1244578. PubMed ID: 37601672
[TBL] [Abstract][Full Text] [Related]
8. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
[TBL] [Abstract][Full Text] [Related]
9. Unlocking the potential of microRNAs: machine learning identifies key biomarkers for myocardial infarction diagnosis.
Samadishadlou M; Rahbarghazi R; Piryaei Z; Esmaeili M; Avcı ÇB; Bani F; Kavousi K
Cardiovasc Diabetol; 2023 Sep; 22(1):247. PubMed ID: 37697288
[TBL] [Abstract][Full Text] [Related]
10. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
11. Normalization matters: tracking the best strategy for sperm miRNA quantification.
Corral-Vazquez C; Blanco J; Salas-Huetos A; Vidal F; Anton E
Mol Hum Reprod; 2017 Jan; 23(1):45-53. PubMed ID: 27932553
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
13. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
14. Identification of characteristic genes and construction of regulatory network in gallbladder carcinoma.
Shao H; Zhu J; Zhu Y; Liu L; Zhao S; Kang Q; Liu Y; Zou H
BMC Med Genomics; 2023 Oct; 16(1):240. PubMed ID: 37821907
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia.
Dong R; Shen Z; Zheng C; Chen G; Zheng S
Sci Rep; 2016 Feb; 6():21084. PubMed ID: 26879603
[TBL] [Abstract][Full Text] [Related]
16. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
Shi XH; Li X; Zhang H; He RZ; Zhao Y; Zhou M; Pan ST; Zhao CL; Feng YC; Wang M; Guo XJ; Qin RY
Sci Rep; 2018 May; 8(1):7638. PubMed ID: 29769534
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of serum-related exosomal miRNAs from parathyroid tumor.
Wang J; Wang Q; Zhao T; Liu X; Bai G; Xin Y; Shen H; Wei B
Endocrine; 2021 Apr; 72(1):239-248. PubMed ID: 33161496
[TBL] [Abstract][Full Text] [Related]
19. Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer.
Shi W; Wartmann T; Accuffi S; Al-Madhi S; Perrakis A; Kahlert C; Link A; Venerito M; Keitel-Anselmino V; Bruns C; Croner RS; Zhao Y; Kahlert UD
Br J Cancer; 2024 Jan; 130(1):125-134. PubMed ID: 37950093
[TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
